Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia

• Príomhchruthaitheoirí: Kabbara WK (Údar), Ramadan WH (Údar), Rahbany P (Údar), Al-Natour S (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Dove Medical Press, 2015-04-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Wissam K Kabbara,1 Wijdan H Ramadan,1 Peggy Rahbany,2 Souhaila Al-Natour3 1Department of Pharmacy Practice, School of Pharmacy, Lebanese American University, Byblos, Lebanon; 2Children’s National Medical Center, Washington, DC, USA; 3Medex Pharmaceutical Company, Beirut, Lebanon Background...